DOI QR코드

DOI QR Code

Thermal Ablation for Renal Cell Carcinoma: Expert Consensus from the Asian Conference on Tumor Ablation

  • Byung Kwan Park (Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Shu-Huei Shen (Department of Radiology, Taipei Veterans General Hospital) ;
  • Masashi Fujimori (Department of Radiology, Mie University School of Medicine) ;
  • Yi Wang (Department of Urology, Peking University Wujieping Urology Center, Peking University Shougang Hospital)
  • Received : 2020.05.28
  • Accepted : 2021.03.19
  • Published : 2021.09.01

Abstract

Keywords

References

  1. Campbell S, Uzzo RG, Allaf ME, Bass EB, Cadeddu JA, Chang A, et al. Renal mass and localized renal cancer: AUA guideline. J Urol 2017;198:520-529 https://doi.org/10.1016/j.juro.2017.04.100
  2. Ljungberg B, Albiges L, Abu-Ghanem Y, Bensalah K, Dabestani S, Fernandez-Pello S, et al. European association of urology guidelines on renal cell carcinoma: the 2019 update. Eur Urol 2019;75:799-810 https://doi.org/10.1016/j.eururo.2019.02.011
  3. Park BK, Kim CK. Percutaneous radio frequency ablation of renal tumors in patients with von Hippel-Lindau disease: preliminary results. J Urol 2010;183:1703-1707 https://doi.org/10.1016/j.juro.2010.01.022
  4. Park BK, Kim CK, Park SY, Shen SH. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease: indications, techniques, complications, and outcomes. Acta Radiol 2013;54:418-427 https://doi.org/10.1177/0284185113475441
  5. Xiaobing W, Wentao G, Guangxiang L, Fan Z, Weidong G, Hongqian G, et al. Comparison of radiofrequency ablation and partial nephrectomy for tumor in a solitary kidney. BMC Urol 2017;17:79
  6. Bhindi B, Mason RJ, Haddad MM, Boorjian SA, Leibovich BC, Atwell TD, et al. Outcomes after cryoablation versus partial nephrectomy for sporadic renal tumors in a solitary kidney: a propensity score analysis. Eur Urol 2018;73:254-259 https://doi.org/10.1016/j.eururo.2017.09.009
  7. Lin Y, Liang P, Yu XL, Yu J, Cheng ZG, Han ZY, et al. Percutaneous microwave ablation of renal cell carcinoma is safe in patients with a solitary kidney. Urology 2014;83:357-363 https://doi.org/10.1016/j.urology.2013.05.071
  8. Park BK, Gong IH, Kang MY, Sung HH, Jeon HG, Jeong BC, et al. RFA versus robotic partial nephrectomy for T1a renal cell carcinoma: a propensity score-matched comparison of midterm outcome. Eur Radiol 2018;28:2979-2985 https://doi.org/10.1007/s00330-018-5305-6
  9. Rosenberg MD, Kim CY, Tsivian M, Suberlak MN, Sopko DR, Polascik TJ, et al. Percutaneous cryoablation of renal lesions with radiographic ice ball involvement of the renal sinus: analysis of hemorrhagic and collecting system complications. AJR Am J Roentgenol 2011;196:935-939 https://doi.org/10.2214/AJR.10.5182
  10. Maciolek KA, Abel EJ, Posielski NM, Hinshaw JL, Lubner MG, Lee FT Jr, et al. Tumor location does not impact oncologic outcomes for percutaneous microwave ablation of clinical T1a renal cell carcinoma. Eur Radiol 2019;29:6319-6329 https://doi.org/10.1007/s00330-019-06121-y
  11. Hudspeth TN, Abdelsalam ME, Sabir SH, Kusin SB, Matin SF, Wood CG, et al. Minimally invasive image guided thermal ablation for recurrent renal cell carcinoma (RCC) after ipsilateral partial nephrectomy. J Clin Oncol 2018;36:e16557
  12. Park SY, Park BK, Kim CK, Lee HM, Jeon SS, Seo SI, et al. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease previously undergoing a radical nephrectomy or repeated nephrons-paring surgery. Acta Radiol 2011;52:680-685 https://doi.org/10.1258/ar.2011.100435
  13. Okhunov Z, Chamberlin J, Moreira DM, George A, Babaian K, Shah P, et al. Salvage percutaneous cryoablation for locally recurrent renal-cell carcinoma after primary cryoablation. J Endourol 2016;30:632-637 https://doi.org/10.1089/end.2016.0088
  14. Uppot RN, Gervais DA. Imaging-guided adrenal tumor ablation. AJR Am J Roentgenol 2013;200:1226-1233 https://doi.org/10.2214/AJR.12.10328
  15. Higgins LJ, Hong K. Renal ablation techniques: state of the art. AJR Am J Roentgenol 2015;205:735-741 https://doi.org/10.2214/AJR.15.14752
  16. Krokidis ME, Orsi F, Katsanos K, Helmberger T, Adam A. CIRSE guidelines on percutaneous ablation of small renal cell carcinoma. Cardiovasc Intervent Radiol 2017;40:177-191 https://doi.org/10.1007/s00270-016-1531-y
  17. Georgiades CS, Hong K, Bizzell C, Geschwind JF, Rodriguez R. Safety and efficacy of CT-guided percutaneous cryoablation for renal cell carcinoma. J Vasc Interv Radiol 2008;19:1302-1310 https://doi.org/10.1016/j.jvir.2008.05.015
  18. Park BK. Low-dose CT protocols for guiding radiofrequency ablation for the treatment of small renal cell carcinomas. Int J Hyperthermia 2018;34:877-882 https://doi.org/10.1080/02656736.2017.1373408
  19. Park BK, Morrison PR, Tatli S, Govindarajulu U, Tuncali K, Judy P, et al. Estimated effective dose of CT-guided percutaneous cryoablation of liver tumors. Eur J Radiol 2012;81:1702-1706 https://doi.org/10.1016/j.ejrad.2011.04.067
  20. Okhunov Z, Juncal S, Ordon M, George AK, Lusch A, del Junco M, et al. Comparison of outcomes in patients undergoing percutaneous renal cryoablation with sedation vs general anesthesia. Urology 2015;85:130-134 https://doi.org/10.1016/j.urology.2014.09.013
  21. Park BK, Kim CK, Choi HY, Lee HM, Jeon SS, Seo SI, et al. Limitation for performing ultrasound-guided radiofrequency ablation of small renal masses. Eur J Radiol 2010;75:248-252 https://doi.org/10.1016/j.ejrad.2009.03.050
  22. Chan P, Velasco S, Vesselle G, Boucebci S, Herpe G, Debaene B, et al. Percutaneous microwave ablation of renal cancers under CT guidance: safety and efficacy with a 2-year follow-up. Clin Radiol 2017;72:786-792 https://doi.org/10.1016/j.crad.2017.03.029
  23. Finley DS, Beck S, Box G, Chu W, Deane L, Vajgrt DJ, et al. Percutaneous and laparoscopic cryoablation of small renal masses. J Urol 2008;180:492-498; discussion 498 https://doi.org/10.1016/j.juro.2008.04.019
  24. Pessoa RR, Autorino R, Laguna MP, Molina WR, Gustafson D, Nogueira L, et al. Laparoscopic versus percutaneous cryoablation of small renal mass: systematic review and cumulative analysis of comparative studies. Clin Genitourin Cancer 2017;15:513-519.e5 https://doi.org/10.1016/j.clgc.2017.02.003
  25. Park BK, Kim CK. Complications of image-guided radiofrequency ablation of renal cell carcinoma: causes, imaging features and prevention methods. Eur Radiol 2009;19:2180-2190 https://doi.org/10.1007/s00330-009-1399-1
  26. Wah TM, Koenig P, Irving HC, Gervais DA, Mueller PR. Radiofrequency ablation of a central renal tumor: protection of the collecting system with a retrograde cold dextrose pyeloperfusion technique. J Vasc Interv Radiol 2005;16:1551-1555 https://doi.org/10.1097/01.RVI.0000175322.05225.0A
  27. Hwang SI, Cho JY, Kim SH, Jun SR, Lee HJ, Moon KC, et al. Protection of the renal collecting system during radiofrequency ablation with antegrade cold dextrose infusion. Radiology 2010;256:759-766 https://doi.org/10.1148/radiol.10091220
  28. Park BK, Kim SH, Byun JY, Kim YS, Kwon GY, Jang IS. CT-guided instillation of 5% dextrose in water into the anterior pararenal space before renal radiofrequency ablation in a porcine model: positive and negative effects. J Vasc Interv Radiol 2007;18:1561-1569 https://doi.org/10.1016/j.jvir.2007.08.026
  29. Silverman SG, Gan YU, Mortele KJ, Tuncali K, Cibas ES. Renal masses in the adult patient: the role of percutaneous biopsy. Radiology 2006;240:6-22 https://doi.org/10.1148/radiol.2401050061
  30. Silverman SG, Israel GM, Herts BR, Richie JP. Management of the incidental renal mass. Radiology 2008;249:16-31 https://doi.org/10.1148/radiol.2491070783
  31. Hegarty NJ, Gill IS, Desai MM, Remer EM, O'Malley CM, Kaouk JH. Probe-ablative nephron-sparing surgery: cryoablation versus radiofrequency ablation. Urology 2006;68:7-13 https://doi.org/10.1016/j.urology.2005.12.049
  32. Laeseke PF, Lee FT Jr, Sampson LA, van der Weide DW, Brace CL. Microwave ablation versus radiofrequency ablation in the kidney: high-power triaxial antennas create larger ablation zones than similarly sized internally cooled electrodes. J Vasc Interv Radiol 2009;20:1224-1229 https://doi.org/10.1016/j.jvir.2009.05.029
  33. Brashears JH, Raj GV, Crisci A, Young MD, Dylewski D, Nelson R, et al. Renal cryoablation and radio frequency ablation: an evaluation of worst case scenarios in a porcine model. J Urol 2005;173:2160-2165 https://doi.org/10.1097/01.ju.0000158125.80981.f1
  34. Janzen NK, Perry KT, Han KR, Kristo B, Raman S, Said JW, et al. The effects of intentional cryoablation and radio frequency ablation of renal tissue involving the collecting system in a porcine model. J Urol 2005;173:1368-1374 https://doi.org/10.1097/01.ju.0000147014.69777.06
  35. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157-163 https://doi.org/10.1016/S0140-6736(03)15268-3
  36. Jih J, Mukherjea A, Vittinghoff E, Nguyen TT, Tsoh JY, Fukuoka Y, et al. Using appropriate body mass index cut points for overweight and obesity among Asian Americans. Prev Med 2014;65:1-6 https://doi.org/10.1016/j.ypmed.2014.04.010
  37. Park JJ, Park BK, Park SY, Kim CK. Percutaneous radiofrequency ablation of sporadic Bosniak III or IV lesions: treatment techniques and short-term outcomes. J Vasc Interv Radiol 2015;26:46-54 https://doi.org/10.1016/j.jvir.2014.09.014
  38. Park BK, Kim CK, Lee HM. Image-guided radiofrequency ablation of Bosniak category III or IV cystic renal tumors: initial clinical experience. Eur Radiol 2008;18:1519-1525 https://doi.org/10.1007/s00330-008-0891-3
  39. Aoun HD, Littrup PJ, Jaber M, Memon F, Adam B, Krycia M, et al. Percutaneous cryoablation of renal tumors: is it time for a new paradigm shift? J Vasc Interv Radiol 2017;28:1363-1370 https://doi.org/10.1016/j.jvir.2017.07.013
  40. Carrafiello G, Dionigi G, Ierardi AM, Petrillo M, Fontana F, Floridi C, et al. Efficacy, safety and effectiveness of image-guided percutaneous microwave ablation in cystic renal lesions Bosniak III or IV after 24 months follow up. Int J Surg 2013;11 Suppl 1:S30-S35 https://doi.org/10.1016/S1743-9191(13)60010-2
  41. Park SY, Park BK, Kim CK. Thermal ablation in renal cell carcinoma: what affects renal function? Int J Hyperthermia 2012;28:729-734 https://doi.org/10.3109/02656736.2012.728017
  42. Knavel EM, Brace CL. Tumor ablation: common modalities and general practices. Tech Vasc Interv Radiol 2013;16:192-200 https://doi.org/10.1053/j.tvir.2013.08.002
  43. Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer 2014;14:199-208 https://doi.org/10.1038/nrc3672
  44. Nikfarjam M, Muralidharan V, Christophi C. Mechanisms of focal heat destruction of liver tumors. J Surg Res 2005;127:208-223 https://doi.org/10.1016/j.jss.2005.02.009
  45. Sommer CM, Lemm G, Hohenstein E, Stampfl U, Bellemann N, Teber D, et al. Bipolar versus multipolar radiofrequency (RF) ablation for the treatment of renal cell carcinoma: differences in technical and clinical parameters. Int J Hyperthermia 2013;29:21-29 https://doi.org/10.3109/02656736.2012.750015
  46. Andrews JR, Atwell T, Schmit G, Lohse CM, Kurup AN, Weisbrod A, et al. Oncologic outcomes following partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2019;76:244-251 https://doi.org/10.1016/j.eururo.2019.04.026
  47. Iannuccilli JD, Dupuy DE, Beland MD, Machan JT, Golijanin DJ, Mayo-Smith WW. Effectiveness and safety of computed tomography-guided radiofrequency ablation of renal cancer: a 14-year single institution experience in 203 patients. Eur Radiol 2016;26:1656-1664 https://doi.org/10.1007/s00330-015-4006-7
  48. Olweny EO, Park SK, Tan YK, Best SL, Trimmer C, Cadeddu JA. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up. Eur Urol 2012;61:1156-1161 https://doi.org/10.1016/j.eururo.2012.01.001
  49. Dai Y, Covarrubias D, Uppot R, Arellano RS. Image-guided percutaneous radiofrequency ablation of central renal cell carcinoma: assessment of clinical efficacy and safety in 31 tumors. J Vasc Interv Radiol 2017;28:1643-1650 https://doi.org/10.1016/j.jvir.2017.05.006
  50. Chang X, Liu T, Zhang F, Ji C, Zhao X, Wang W, et al. Radiofrequency ablation versus partial nephrectomy for clinical T1a renal-cell carcinoma: long-term clinical and oncologic outcomes based on a propensity score analysis. J Endourol 2015;29:518-525 https://doi.org/10.1089/end.2014.0864
  51. Takaki H, Yamakado K, Soga N, Arima K, Nakatsuka A, Kashima M, et al. Midterm results of radiofrequency ablation versus nephrectomy for T1a renal cell carcinoma. Jpn J Radiol 2010;28:460-468 https://doi.org/10.1007/s11604-010-0451-z
  52. Hasegawa T, Yamanaka T, Gobara H, Miyazaki M, Takaki H, Sato Y, et al. Radiofrequency ablation versus cryoablation for T1b renal cell carcinoma: a multi-center study. Jpn J Radiol 2018;36:551-558 https://doi.org/10.1007/s11604-018-0756-x
  53. Zhou W, Arellano RS. Thermal ablation of T1c renal cell carcinoma: a comparative assessment of technical performance, procedural outcome, and safety of microwave ablation, radiofrequency ablation, and cryoablation. J Vasc Interv Radiol 2018;29:943-951 https://doi.org/10.1016/j.jvir.2017.12.020
  54. Takaki H, Soga N, Kanda H, Nakatsuka A, Uraki J, Fujimori M, et al. Radiofrequency ablation versus radical nephrectomy: clinical outcomes for stage T1b renal cell carcinoma. Radiology 2014;270:292-299 https://doi.org/10.1148/radiol.13130221
  55. Atwell TD, Carter RE, Schmit GD, Carr CM, Boorjian SA, Curry TB, et al. Complications following 573 percutaneous renal radiofrequency and cryoablation procedures. J Vasc Interv Radiol 2012;23:48-54 https://doi.org/10.1016/j.jvir.2011.09.008
  56. Weizer AZ, Raj GV, O'Connell M, Robertson CN, Nelson RC, Polascik TJ. Complications after percutaneous radiofrequency ablation of renal tumors. Urology 2005;66:1176-1180 https://doi.org/10.1016/j.urology.2005.06.125
  57. Hoffmann NE, Bischof JC. The cryobiology of cryosurgical injury. Urology 2002;60:40-49 https://doi.org/10.1016/S0090-4295(02)01683-7
  58. Mazur P. Freezing of living cells: mechanisms and implications. Am J Physiol 1984;247:C125-C142 https://doi.org/10.1152/ajpcell.1984.247.3.C125
  59. Atwell TD, Schmit GD, Boorjian SA, Mandrekar J, Kurup AN, Weisbrod AJ, et al. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation. AJR Am J Roentgenol 2013;200:461-466 https://doi.org/10.2214/AJR.12.8618
  60. Pirasteh A, Snyder L, Boncher N, Passalacqua M, Rosenblum D, Prologo JD. Cryoablation vs. radiofrequency ablation for small renal masses. Acad Radiol 2011;18:97-100 https://doi.org/10.1016/j.acra.2010.08.006
  61. Thompson RH, Atwell T, Schmit G, Lohse CM, Kurup AN, Weisbrod A, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2015;67:252-259 https://doi.org/10.1016/j.eururo.2014.07.021
  62. Kunkle DA, Egleston BL, Uzzo RG. Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review. J Urol 2008;179:1227-1233; discussion 1233-1234 https://doi.org/10.1016/j.juro.2007.11.047
  63. Klatte T, Grubmuller B, Waldert M, Weibl P, Remzi M. Laparoscopic cryoablation versus partial nephrectomy for the treatment of small renal masses: systematic review and cumulative analysis of observational studies. Eur Urol 2011;60:435-443 https://doi.org/10.1016/j.eururo.2011.05.002
  64. Caputo PA, Zargar H, Ramirez D, Andrade HS, Akca O, Gao T, et al. Cryoablation versus partial nephrectomy for clinical T1b renal tumors: a matched group comparative analysis. Eur Urol 2017;71:111-117 https://doi.org/10.1016/j.eururo.2016.08.039
  65. Garnon J, Van Strijen MJ, Nielsen TK, King AJ, Montauban Van Swijndregt AD, Cazzato RL, et al. Safety of percutaneous renal cryoablation: an international multicentre experience from the EuRECA retrospective percutaneous database. Eur Radiol 2019;29:6293-6299 https://doi.org/10.1007/s00330-019-06191-y
  66. Schmit GD, Schenck LA, Thompson RH, Boorjian SA, Kurup AN, Weisbrod AJ, et al. Predicting renal cryoablation complications: new risk score based on tumor size and location and patient history. Radiology 2014;272:903-910 https://doi.org/10.1148/radiol.14132548
  67. Zargar H, Atwell TD, Cadeddu JA, de la Rosette JJ, Janetschek G, Kaouk JH, et al. Cryoablation for small renal masses: selection criteria, complications, and functional and oncologic results. Eur Urol 2016;69:116-128 https://doi.org/10.1016/j.eururo.2015.03.027
  68. Sommer CM, Sommer SA, Mokry T, Gockner T, Gnutzmann D, Bellemann N, et al. Quantification of tissue shrinkage and dehydration caused by microwave ablation: experimental study in kidneys for the estimation of effective coagulation volume. J Vasc Interv Radiol 2013;24:1241-1248 https://doi.org/10.1016/j.jvir.2013.04.008
  69. Brace CL. Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: what are the differences? Curr Probl Diagn Radiol 2009;38:135-143 https://doi.org/10.1067/j.cpradiol.2007.10.001
  70. Yu J, Liang P, Yu X, Liu F, Chen L, Wang Y. A comparison of microwave ablation and bipolar radiofrequency ablation both with an internally cooled probe: results in ex vivo and in vivo porcine livers. Eur J Radiol 2011;79:124-130 https://doi.org/10.1016/j.ejrad.2009.12.009
  71. Uhlig J, Strauss A, Rucker G, Seif Amir Hosseini A, Lotz J, Trojan L, et al. Partial nephrectomy versus ablative techniques for small renal masses: a systematic review and network meta-analysis. Eur Radiol 2019;29:1293-1307 https://doi.org/10.1007/s00330-018-5660-3
  72. Atwell TD, Vlaminck JJ, Boorjian SA, Kurup AN, Callstrom MR, Weisbrod AJ, et al. Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control. J Vasc Interv Radiol 2015;26:792-799 https://doi.org/10.1016/j.jvir.2015.02.010
  73. Lee HJ, Chung HJ, Wang HK, Shen SH, Chang YH, Chen CK, et al. Evolutionary magnetic resonance appearance of renal cell carcinoma after percutaneous cryoablation. Br J Radiol 2016;89:20160151